Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.
Balagopal A, Asmuth DM, Yang WT, Campbell TB, Gupte N, Smeaton L, Kanyama C, Grinsztejn B, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo UG, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Li XD, Pollard RB, Semba RD, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study team. Balagopal A, et al. Among authors: li xd. J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):163-71. doi: 10.1097/QAI.0000000000000696. J Acquir Immune Defic Syndr. 2015. PMID: 26017661 Free PMC article.
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.
Rodriguez B, Asmuth DM, Matining RM, Spritzler J, Jacobson JM, Mailliard RB, Li XD, Martinez AI, Tenorio AR, Lori F, Lisziewicz J, Yesmin S, Rinaldo CR, Pollard RB. Rodriguez B, et al. Among authors: li xd. J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):351-9. doi: 10.1097/QAI.0b013e3182a99590. J Acquir Immune Defic Syndr. 2013. PMID: 24169120 Free PMC article. Clinical Trial.
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.
Asmuth DM, Murphy RL, Rosenkranz SL, Lertora JJ, Kottilil S, Cramer Y, Chan ES, Schooley RT, Rinaldo CR, Thielman N, Li XD, Wahl SM, Shore J, Janik J, Lempicki RA, Simpson Y, Pollard RB; AIDS Clinical Trials Group A5192 Team. Asmuth DM, et al. Among authors: li xd. J Infect Dis. 2010 Jun 1;201(11):1686-96. doi: 10.1086/652420. J Infect Dis. 2010. PMID: 20420510 Free PMC article. Clinical Trial.
Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes.
Asmuth DM, Wang N, Lu Y, Li XD, Reece L, Terry NH, Pollard RB, Nokta M, Leary JF, White RA. Asmuth DM, et al. Among authors: li xd. Cytometry A. 2005 Jul;66(1):41-51. doi: 10.1002/cyto.a.20148. Cytometry A. 2005. PMID: 15915506 Free article.
The safety and tolerability of Z-100 in patients infected with HIV-1.
Borucki M, Holodniy M, Pierone G Jr, Ruane P, Steinhart C, Williams S, Slom T, Palella F Jr, Hare CB, Yoshidao Y, Li XD, Pollard RB. Borucki M, et al. Among authors: li xd. Antivir Ther. 2006;11(3):297-303. Antivir Ther. 2006. PMID: 16759045 Clinical Trial.
1,523 results